Videos and Podcasts
Pharmaxis Investor Briefing Recording | Jul 29 2022
Pharmaxis Ltd (ASX: PXS) released its Quarterly Shareholder Update on the morning of 29 July 2022.
Investors and analysts joined the Company for a virtual investor briefing by chief executive officer Mr Gary Phillips.
The event consisted of a short presentation of the Company’s progress over the past quarter and future plans followed by a Q&A session from attendees. You can watch a recording of the presentation below.
MST Access: Clinical trials on track; news flow ahead
Chris Kallos of MST Access discusses Pharmaxis clinical trial program with CEO Gary Phillips.
Watch the interview here.
MST Financial (“MST”) materials, or any portion thereof, may not be reproduced, sold or redistributed without the prior and written consent of MST. MST Access reports, updates, video interviews and other materials produced by MST Access have generally been engaged and paid by the subject company for ongoing research coverage. Please refer to full disclosures and disclaimers in the company-specific reports.Pharmaxis Quarterly Investor Update- 29 April 2022.
Pharmaxis Ltd (ASX: PXS) released its Quarterly Shareholder Update on the morning of 29 April 2022.
Investors and analysts joined the Company for a virtual investor briefing by chief executive officer Mr Gary Phillips.
The event consisted of a short presentation of the Company’s progress over the past quarter and future plans followed by a Q&A session from attendees. You can watch a recording of the presentation here.